Latest news
Loading news…
Intercell
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Vienna, Wien, Austria Founded 1998 251-500 employees For Profit
Intercell is a biotechnology company, engages in the design and development of vaccines for the prevention and treatment of infectious.
Intercell was acquired by Vivalis in 2012 for $174M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
1
Monthly Visits
Available in Pro Contacts
0
Patents
17
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Delisted
- Ticker
- ICLL
- Exchange
- VIE
- IPO date
- Feb 28, 2005
- Delisted
- May 28, 2013
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 1
- Active products
- 5
- Patents granted
- 17
- Trademarks
- 0
- Top patent class
- c07
- IT spend
- $9M
Company Info
- Founded
- 1998
- Employees
- 251-500
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- News articles
- 10
- HQ
- Vienna, Wien, Austria
- Region
- European Union (EU), Europe, Middle East, and Africa (EMEA)
- Exit date
- Feb 28, 2005
- Closed
- May 27, 2013
Signals & Scores
- Heat score
- Low
- Trend (7d)
- -0.2
- Trend (30d)
- 0.4
- Trend (90d)
- 1.1
Acquisitions by Intercell
Loading columns…
0 of 0Show
Page 1 / 1
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Intercell
Loading news…
FAQs about Intercell
People who checked this page also checked these
Sectors Intercell invests & acquires in
Browse the full Acquirezy directory.